Massachusetts AG’s Office Reaches $3.5 Million Settlement With Aspen Dental

Article

Dental company to return money to patients; will be subject to new advertising restrictions after claims of deceptive advertising.

Aspen Dental settlement

The Massachusetts Attorney General’s Office announced on Jan. 5 a $3.5 million settlement with Aspen Dental Management, Inc. (Aspen Dental) resolving claims that the dental chain cheated thousands of Massachusetts consumers through a series of bait-and-switch advertising campaigns.

The consent judgment, entered in Suffolk Superior Court , settles a lawsuit filed by Attorney General Maura Healey in December 2021alleging that Aspen Dental violated the state Consumer Protection Law and the assurances Aspen Dental made to the AG’s Office in a settlement back in 2014 that addressed similar conduct. According to the AG’s lawsuit, Aspen Dental engaged in numerous deceptive advertising and marketing practices, including charging patients for services it advertised as “free,” as well as advertising that it worked with “all” insurance when it did not accept MassHealth, the Massachusetts Medicaid program that includes dental coverage.

According to the Massachusetts Attorney General’s Office, the consent judgment follows an April 2022 court order that prohibited Aspen Dental from running “all insurance” advertisements without adequate disclosures.

“Deceptive advertisements like these can harm our most vulnerable patients looking for affordable dental care,” Acting AG Bessie Dewar says in a press release. “Today’s settlement prevents misleading advertising by Aspen Dental and puts money back in the hands of impacted patients.”

The AG’s lawsuit alleged that Aspen Dental engaged in a multi-faceted scheme to deceive consumers into purchasing dental services and products at the more than 25 Aspen Dental-branded dental offices in Massachusetts. According to the lawsuit, Aspen Dental also sent consumers to collections over bills for services it had advertised as “free.”

Under the terms of the settlement, Aspen Dental will pay $3.5 million including by returning up to $750,000 to patients who paid for new patient examinations, x-rays and oral cancer screenings at Aspen Dental-branded offices in the state.

The settlement also prohibits Aspen Dental from using advertisements that misleadingly offer “free” services, state that Aspen Dental works with “all” insurance, reference guarantees or denture prices, or indicate that Aspen Dental offices have “no hidden fees.” It also contains restrictions related to communications concerning oral cancer screenings and debt collection.

This matter was handled by Assistant Attorneys General Ethan Marks and Emiliano

Mazlen of the AG’s Health Care Division, with assistance from Division Chief Eric Gold, Assistant Attorney General Michael Wong, Paralegal Maya Al-Ahmad, and Mediator Juan Sosa of the AG’s Health Care Division and Senior Investigator Anthony Crespi of the AG’s Civil Investigations Division.

Recent Videos
GNYDM24 Product Focus: Sonya Dunbar, RDH, shares her passion about the importance of geriatric oral care in mobile dentistry and long-term care facilities.
GNYDM24 Product Focus: Michele Gabriel of DDSmatch stops by the DPR booth at the Javits Center in New York.
GNYDM24 Product Focus: Debra Engelhardt-Nash talks about how Weave's systems can help with increasing patient acceptance and with practices getting paid.
DS World 2024 Interview with Katrina Sanders, RDH
Mastermind 42 – Episode 42 – Getting Those 5-Star Reviews for Your Dental Practice Part 2
Mastermind – Episode 39 – Resolving Conflicts in the Dental Practice
Mastermind – Episode 38 – Providing Dental Care for Older Patient Populations
2024 Dental Products Report Spring Selection Bracket Reveal Video
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
Related Content
© 2024 MJH Life Sciences

All rights reserved.